A blood aging clock defines disease-induced deviation from healthy molecular aging
Briefings in Bioinformatics · 01.09.2026 · 27 (5)
DOI: 10.1093/bib/bbag605 ↗Kurz gefasst
Fachartikel in der Zeitschrift Briefings in Bioinformatics, online erschienen am 30.10.2026. Verfasst von Haotian Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural Medicines, China Pharmaceutical University, 639 Longmian Avenue, Jiangning District, Nanjing 211198, Jiangsu, China. Hauptthemen laut MEDLINE: Aging, COVID-19, Transcriptome. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities, Young Elite Scientists Sponsorship Program by CAST.
Abstract (Originalsprache)
Aging shapes disease susceptibility and recovery, yet it remains unclear whether disease-induced molecular perturbations can be quantitatively mapped onto healthy aging trajectories. Here, we integrated 10 753 whole-blood transcriptomic profiles from 23 cohorts and developed a blood aging predictor (BAP) using 5808 healthy individuals to define a reference trajectory of blood molecular aging. Applying BAP to COVID-19 revealed marked transcriptomic age acceleration (AgeAccel), with patients showing an average AgeAccel of 9.34 years after cohort-specific baseline correction. This aging-referenced deviation occurred across age groups and was associated with interferon signaling, immune-inflammatory activation, cytokine and neutrophil-related programs, DNA damage responses, proteostasis stress, and impaired cellular quality-control pathways. Longitudinal analysis showed that AgeAccel increased during acute infection but declined during recovery, indicating a potentially reversible aging-like molecular state at the cohort level rather than irreversible aging. Extension to sepsis, influenza, and major depressive disorder further demonstrated that elevated AgeAccel captures disease-associated molecular burden across distinct pathological contexts. Together, our study redefines transcriptomic AgeAccel as an interpretable measure of disease-induced deviation from healthy molecular homeostasis and provides a quantitative framework for assessing systemic disease burden and recovery dynamics from peripheral blood transcriptomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Natural Medicines, China Pharmaceutical University, 639 Longmian Avenue, Jiangning District, Nanjing 211198, Jiangsu, China.
- Department of Computer Science, RWTH Aachen University, Ahornstr. 55, Aachen 52074, Germany.
- School of Pharmacy, The University of Nottingham, University Park, Nottingham NG7 2RD, United Kingdom.
ORCID-Profile: Xinuo Li
Förderung
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
- Young Elite Scientists Sponsorship Program by CAST
- Sanming Project of Medicine in Shenzhen
- Haihe Laboratory of Cell Ecosystem Innovation Fund
Zitieren
APA
Li, H., Liu, S., Zhou, Z., Lu, Q., Wang, G., Zhu, Z., & Li, X. (2026). A blood aging clock defines disease-induced deviation from healthy molecular aging. Briefings in Bioinformatics, 27(5). https://doi.org/10.1093/bib/bbag605
Vancouver
Li H, Liu S, Zhou Z, Lu Q, Wang G, Zhu Z, et al. A blood aging clock defines disease-induced deviation from healthy molecular aging. Briefings in Bioinformatics. 2026;27(5). doi:10.1093/bib/bbag605
BibTeX
@article{Li2026,
author = {Li, Haotian and Liu, Sai and Zhou, Zheng and Lu, Qiulun and Wang, Guangji and Zhu, Zheying and Li, Xinuo},
title = {A blood aging clock defines disease-induced deviation from healthy molecular aging},
journal = {Briefings in Bioinformatics},
year = {2026},
volume = {27},
number = {5},
doi = {10.1093/bib/bbag605}
}
EUVIMED